Journal of Molecular and Cellular Cardiology
Volume 50, Issue 1 , Pages 25-32 , January 2011

Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells

  • Daphne de Groot

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Both authors contributed equally to the manuscript.
    • ,
  • Imo E. Hoefer

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Both authors contributed equally to the manuscript.
    • ,
  • Sebastian Grundmann

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Department of Cardiology, AMC, University of Amsterdam, The Netherlands
    • ,
  • Arjan Schoneveld

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Interuniversity Cardiology Institute Netherlands, Utrecht, The Netherlands
    • ,
  • René T. Haverslag

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • ,
  • J. Karlijn van Keulen

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Department of Cardiology, AMC, University of Amsterdam, The Netherlands
    • ,
  • Pieter T. Bot

      Affiliations

    • Department of Cardiology, AMC, University of Amsterdam, The Netherlands
    • ,
  • Leo Timmers

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Department of Cardiology, AMC, University of Amsterdam, The Netherlands
    • ,
  • Jan J. Piek

      Affiliations

    • Department of Cardiology, AMC, University of Amsterdam, The Netherlands
    • ,
  • Gerard Pasterkamp

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • ,
  • Dominique P.V. de Kleijn

      Affiliations

    • Laboratory of Experimental Cardiology, HLCU, UMC, University of Utrecht, The Netherlands
    • Interuniversity Cardiology Institute Netherlands, Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. UMC Utrecht, Lab. of Experimental Cardiology, G02.523, Heidelberglaan 100, NL-3584 CX Utrecht, The Netherlands. Tel.: +31 88 755 7155; fax: +31 30 252 2693.

Received 19 March 2010 ,Revised 2 August 2010 ,Accepted 3 August 2010.

References 

  1. van Oostrom MC, van Oostrom O, Quax PH, Verhaar MC, Hoefer IE. Insights into mechanisms behind arteriogenesis: what does the future hold?. J Leukoc Biol. 2008;84:1379–1391
  2. Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM, et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol. 2006;80:59–65
  3. van Weel V, Toes RE, Seghers L, Deckers MM, de Vries MR, Eilers PH, et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol. 2007;27:2310–2318
  4. Hoefer IE, van Royen N, Rectenwald JE, Deindl E, Hua J, Jost M, et al. Arteriogenesis proceeds via ICAM-1/Mac-1-mediated mechanisms. Circ Res. 2004;94:1179–1185
  5. Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res. 2001;49:609–617
  6. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829–837
  7. Ieda Y, Fujita J, Ieda M, Yagi T, Kawada H, Ando K, et al. G-CSF and HGF: combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. J Mol Cell Cardiol. 2007;42:540–548
  8. He Y, Luo Y, Tang S, Rajantie I, Salven P, Heil M, et al. Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest. 2006;116:2344–2355
  9. Scholz D, Elsaesser H, Sauer A, Friedrich C, Luttun A, Carmeliet P, et al. Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) -/- mice. J Mol Cell Cardiol. 2003;35:177–184
  10. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164:558–561
  11. Soltys BJ, Gupta RS. Cell surface localization of the 60kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int. 1997;21:315–320
  12. Wand-Wurttenberger A, Schoel B, Ivanyi J, Kaufmann SH. Surface expression by mononuclear phagocytes of an epitope shared with mycobacterial heat shock protein 60. Eur J Immunol. 1991;21:1089–1092
  13. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229–10233
  14. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999;5:1249–1255
  15. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40–50
  16. Norata GD, Garlaschelli K, Ongari M, Raselli S, Grigore L, Benvenuto F, et al. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med. 2005;258:21–27
  17. Shishido T, Nozaki N, Takahashi H, Arimoto T, Niizeki T, Koyama Y, et al. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochem Biophys Res Commun. 2006;345:1446–1453
  18. Vink A, Schoneveld AH, van der Meer JJ, Van Middelaar BJ, Sluijter JP, Smeets MB, et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation. 2002;106:1985–1990
  19. Cai WJ, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, et al. Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol Heart Circ Physiol. 2003;284:H31–H40
  20. Weihrauch D, Zimmermann R, Arras M, Schaper J. Expression of extracellular matrix proteins and the role of fibroblasts and macrophages in repair processes in ischemic porcine myocardium. Cell Mol Biol Res. 1994;40:105–116
  21. Hollestelle SC, de Vries MR, Van Keulen JK, Schoneveld AH, Vink A, Strijder CF, et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation. 2004;109:393–398
  22. Poltorak A, He X, Smirnova I, Liu MY, Van HC, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–2088
  23. Vogel SN, Johnson D, Perera PY, Medvedev A, Lariviere L, Qureshi ST, et al. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J Immunol. 1999;162:5666–5670
  24. Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, et al. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation. 2002;105:1639–1641
  25. Sluijter JP, Smeets MB, Velema E, Pasterkamp G, de Kleijn DP. Increase in collagen turnover but not in collagen fiber content is associated with flow-induced arterial remodeling. J Vasc Res. 2004;41:546–555
  26. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol. 2002;34:775–787
  27. Helisch A, Wagner S, Khan N, Drinane M, Wolfram S, Heil M, et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol. 2006;26:520–526
  28. Zbinden S, Clavijo LC, Kantor B, Morsli H, Cortes GA, Andrews JA, et al. Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials. Am J Physiol Heart Circ Physiol. 2007;292:H1891–H1897
  29. Lefebvre JS, Marleau S, Milot V, Levesque T, Picard S, Flamand N, et al. Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor. FASEB J. 2010;24:637–647
  30. Sabroe I, Dower SK, Whyte MK. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis. 2005;41(Suppl 7):S421–S426
  31. Timmers L, Sluijter JP, Van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 2008;102:257–264
  32. da Silva CJ, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem. 2001;276:21129–21135
  33. McCurdy JD, Lin TJ, Marshall JS. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol. 2001;70:977–984
  34. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002;169:2026–2033
  35. Macedo L, Pinhal-Enfield G, Alshits V, Elson G, Cronstein BN, Leibovich SJ. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol. 2007;171:1774–1788
  36. Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY, et al. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett. 2007;108:121–128
  37. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol. 2003;163:711–721
  38. Varoga D, Paulsen F, Mentlein R, Fay J, Kurz B, Schutz R, et al. TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease. J Pathol. 2006;210:315–324
  39. Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G, et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol. 2004;24:1664–1668
  40. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics. 2007;30:179–191
  41. Taherzadeh Z, VanBavel E, De Vos J, Matlung HL, Van Mobtfrans G, Brewster LM, et al. Strain-dependent susceptibility for hypertension in mice resides in the natural killer gene complex. Am J Physiol Heart Circ Physiol. 2010;298:H1273–H1282
  42. Jiang X, Shen C, Yu H, Karunakaran KP, Brunham RC. Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology. 2010;129:556–566
  43. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem. 2000;275:11058–11063
  44. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105:1158–1161
  45. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation. 2008;118:1276–1284
  46. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, et al. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2007;27:1064–1071
  47. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101:10679–10684
  48. Yang QW, Mou L, Lv FL, Wang JZ, Wang L, Zhou HJ, et al. Role of Toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL. Biorheology. 2005;42:225–236
  49. Bausinger H, Lipsker D, Ziylan U, Manie S, Briand JP, Cazenave JP, et al. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur J Immunol. 2002;32:3708–3713
  50. Chen K, Lu J, Wang L, Gan YH. Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling. J Leukoc Biol. 2004;75:260–266
  51. Gao B, Tsan MF. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J Biol Chem. 2003;278:22523–22529
  52. Gao B, Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem. 2003;278:174–179
  53. Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis. 2008;197:95–104

PII: S0022-2828(10)00293-2

doi: 10.1016/j.yjmcc.2010.08.006

Journal of Molecular and Cellular Cardiology
Volume 50, Issue 1 , Pages 25-32 , January 2011

Article Tools

* Image Usage & Resolution